Socio-economically deprived families’ routes to family-based addiction prevention services von Pfister, A, Wyss, S, Koschmieder, N

Volltext

Suicide attempts in LGBTQ+ youth in Switzerland: Qualitative insights in school-based risk factors: Niolyne Jasmin Bomolo von Bomolo, NJ, Koschmieder, N, Gavin, A, Kupferschmid, S, Bourquin, C, Michaud, L, Pfister, A

Volltext

Suicide attempts in LGBTQ+ youth in Switzerland: Qualitative insights in school-based risk factors von Bomolo, NJ, Koschmieder, N, Gavin, A, Kupferschmid, S, Bourquin, C, Michaud, L, Pfister, A

Volltext

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet von Barbui, Tiziano, Tefferi, Ayalew, Vannucchi, Alessandro M., Passamonti, Francesco, Silver, Richard T., Hoffman, Ronald, Verstovsek, Srdan, Mesa, Ruben, Kiladjian, Jean-Jacques, Hehlmann, Rȕdiger, Reiter, Andreas, Cervantes, Francisco, Harrison, Claire, Mc Mullin, Mary Frances, Hasselbalch, Hans Carl, Koschmieder, Steffen, Marchetti, Monia, Bacigalupo, Andrea, Finazzi, Guido, Kroeger, Nicolaus, Griesshammer, Martin, Birgegard, Gunnar, Barosi, Giovanni

Volltext

Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia von Müller-Tidow, C, Tschanter, P, Röllig, C, Thiede, C, Koschmieder, A, Stelljes, M, Koschmieder, S, Dugas, M, Gerss, J, Butterfaß-Bahloul, T, Wagner, R, Eveslage, M, Thiem, U, Krause, S W, Kaiser, U, Kunzmann, V, Steffen, B, Noppeney, R, Herr, W, Baldus, C D, Schmitz, N, Götze, K, Reichle, A, Kaufmann, M, Neubauer, A, Schäfer-Eckart, K, Hänel, M, Peceny, R, Frickhofen, N, Kiehl, M, Giagounidis, A, Görner, M, Repp, R, Link, H, Kiani, A, Naumann, R, Brümmendorf, T H, Serve, H, Ehninger, G, Berdel, W E, Krug, U

Volltext

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry von Kaifie, A, Kirschner, M, Wolf, D, Maintz, C, Hänel, M, Gattermann, N, Gökkurt, E, Platzbecker, U, Hollburg, W, Göthert, J R, Parmentier, S, Lang, F, Hansen, R, Isfort, S, Schmitt, K, Jost, E, Serve, H, Ehninger, G, Berdel, W E, Brümmendorf, T H, Koschmieder, S

Volltext

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes von Krug, Utz, Dr, Röllig, Christoph, MD, Koschmieder, Anja, Heinecke, Achim, PhD, Sauerland, Maria Cristina, MSc, Schaich, Markus, Prof, Thiede, Christian, Prof, Kramer, Michael, Braess, Jan, Prof, Spiekermann, Karsten, MD, Haferlach, Torsten, Prof, Haferlach, Claudia, MD, Koschmieder, Steffen, MD, Rohde, Christian, PhD, Serve, Hubert, Prof, Wörmann, Bernhard, Prof, Hiddemann, Wolfgang, Prof, Ehninger, Gerhard, Prof, Berdel, Wolfgang E, Prof, Büchner, Thomas, Prof, Müller-Tidow, Carsten, Prof

Volltext

The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey von Harrison, Claire N., Koschmieder, Steffen, Foltz, Lynda, Guglielmelli, Paola, Flindt, Tina, Koehler, Michael, Mathias, Jonathan, Komatsu, Norio, Boothroyd, Robert N., Spierer, Amber, Perez Ronco, Julian, Taylor-Stokes, Gavin, Waller, John, Mesa, Ruben A.

Volltext

Myelofibrosis: Current unmet needs, emerging treatments, and future perspectives von Harrison, Claire N., Kiladjian, Jean‐Jacques, Koschmieder, Steffen, Passamonti, Francesco

Volltext

Consensus-Based Best Practice Recommendations for Myelofibrosis Management in Routine Clinical Practice with a Focus on Patients with Cytopenias: Systematic Literature Review and C... von Harrison, Claire N, Bose, Prithviraj, Ellis, Martin H., Gupta, Vikas, Kiladjian, Jean-Jacques, Mascarenhas, John, Mathews, Vikram, Passamonti, Francesco, Koschmieder, Steffen

Volltext

Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms von Pritchard, Jessica E., Pearce, Juliette E., Snoeren, Inge A.M., Fuchs, Stijn N.R., Götz, Katrin, Peisker, Fabian, Wagner, Silke, Benabid, Adam, Lutterbach, Niklas, Klöker, Vanessa, Nagai, James S., Hannani, Monica T., Galyga, Anna K., Sistemich, Ellen, Banjanin, Bella, Flosdorf, Niclas, Bindels, Eric, Olschok, Kathrin, Biaesch, Katharina, Chatain, Nicolas, Bhagwat, Neha, Dunbar, Andrew, Sarkis, Rita, Naveiras, Olaia, Berres, Marie-Luise, Koschmieder, Steffen, Levine, Ross L., Costa, Ivan G., Gleitz, Hélène F.E., Kramann, Rafael, Schneider, Rebekka K.

Volltext

A ‘telomere-associated secretory phenotype’ cooperates with BCR-ABL to drive malignant proliferation of leukemic cells von Braig, M, Pällmann, N, Preukschas, M, Steinemann, D, Hofmann, W, Gompf, A, Streichert, T, Braunschweig, T, Copland, M, Rudolph, K L, Bokemeyer, C, Koschmieder, S, Schuppert, A, Balabanov, S, Brümmendorf, T H

Volltext

Rare FLT3 deletion mutants may provide additional treatment options to patients with AML: an approach to individualized medicine von Chatain, N, Perera, R C, Rossetti, G, Rossa, J, Carloni, P, Schemionek, M, Haferlach, T, Brümmendorf, T H, Schnittger, S, Koschmieder, S

Volltext

JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms von Rao, Tata Nageswara, Hansen, Nils, Hilfiker, Julian, Rai, Shivam, Majewska, Julia-Magdalena, Leković, Danijela, Gezer, Deniz, Andina, Nicola, Galli, Serena, Cassel, Teresa, Geier, Florian, Delezie, Julien, Nienhold, Ronny, Hao-Shen, Hui, Beisel, Christian, Di Palma, Serena, Dimeloe, Sarah, Trebicka, Jonel, Wolf, Dominik, Gassmann, Max, Fan, Teresa W.-M., Lane, Andrew N., Handschin, Christoph, Dirnhofer, Stefan, Kröger, Nicolaus, Hess, Christoph, Radimerski, Thomas, Koschmieder, Steffen, Čokić, Vladan P., Skoda, Radek C.

Volltext

Mtss1 is a critical epigenetically regulated tumor suppressor in CML von Schemionek, M, Herrmann, O, Reher, M M, Chatain, N, Schubert, C, Costa, I G, Hänzelmann, S, Gusmao, E G, Kintsler, S, Braunschweig, T, Hamilton, A, Helgason, G V, Copland, M, Schwab, A, Müller-Tidow, C, Li, S, Holyoake, T L, Brümmendorf, T H, Koschmieder, S

Volltext

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study von Guglielmelli, Paola, Biamonte, Flavia, Rotunno, Giada, Artusi, Valentina, Artuso, Lucia, Bernardis, Isabella, Tenedini, Elena, Pieri, Lisa, Paoli, Chiara, Mannarelli, Carmela, Fjerza, Rajmonda, Rumi, Elisa, Stalbovskaya, Viktoriya, Squires, Matthew, Cazzola, Mario, Manfredini, Rossella, Harrison, Claire, Tagliafico, Enrico, Vannucchi, Alessandro M.

Volltext

Characteristics of High-Risk Polycythemia Vera Patients with Suboptimal Response to First-Line Therapy Who Switched to Ruxolitinib Vs Those Who Did Not Switch: Findings from PV-Swi... von Koschmieder, Steffen, Schulte, Clemens, von der Heyde, Eyck, Busque, Lambert, Boyer-Perrard, Françoise, Devos, Timothy, Passamonti, Francesco, Zuurman, Mike W., Paley, Carole, Gilotti, Geralyn, Cheng, Wendy Y., Gao, Chi, Cheng, Mu, Wu, Melody, Duh, Mei Sheng, Harrison, Claire N.

Volltext

A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 (Int-2) or High-Risk Myelofibrosis (MF) Refractory... von Mascarenhas, John, Harrison, Claire N., Kiladjian, Jean-Jacques, Komrokji, Rami S., Koschmieder, Steffen, Vannucchi, Alessandro, Berry, Tymara, Sherman, Laurie, Dougherty, Souria, Sun, Libo, Huang, Fei, Wan, Ying, Feller, Faye, Rizo, Aleksandra, Verstovsek, Srdan

Volltext

Imetelstat in intermediate-2 or high-risk myelofibrosis refractory to JAK inhibitor: IMpactMF phase III study design von Mascarenhas, John, Harrison, Claire N, Kiladjian, Jean-Jacques, Komrokji, Rami S, Koschmieder, Steffen, Vannucchi, Alessandro M, Berry, Tymara, Redding, Denise, Sherman, Laurie, Dougherty, Souria, Peng, Lixian, Sun, Libo, Huang, Fei, Wan, Ying, Feller, Faye M, Rizo, Aleksandra, Verstovsek, Srdan

Volltext

A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Advanced Myelofibrosis von Gill, Harinder, Yacoub, Abdulraheem, Pettit, Kristen M., Bradley, Terrence, Gerds, Aaron T., Tatarczuch, Maciej, Shortt, Jake, Curtin, Natasha Joan, Rossetti, James M., Burbury, Kate, Mead, Adam J., Göthert, Joachim R., Koschmieder, Steffen, Jones, Amber, Peppe, Jennifer, Natsoulis, Georges, Hong, Wan-Jen, Stevenson, William S., Ewing, Joanne, Harrison, Claire N., Vannucchi, Alessandro, Watts, Justin, Ross, David M, Talpaz, Moshe, Rienhoff, Hugh Young

Volltext